Also known as: Hepatx Corporation
Replacing organ transplant with an infusion
Company is active
Event Year: 2018
Company is active
Event Year: 2018
Hepatx is dedicated to revolutionizing the treatment of chronic liver disease through regenerative medicine. Their core mission is to develop innovative therapies that can effectively repair diseased and damaged liver tissues, ultimately eliminating the need for organ transplantation. Hepatx envisions a future where regenerative medicine provides lasting solutions for patients suffering from liver ailments, offering a path towards restored health and improved quality of life.
Hepatx is dedicated to revolutionizing the treatment of chronic liver disease through regenerative medicine. Their core mission is to develop innovative therapies that can effectively repair diseased and damaged liver tissues, ultimately eliminating the need for organ transplantation. Hepatx envisions a future where regenerative medicine provides lasting solutions for patients suffering from liver ailments, offering a path towards restored health and improved quality of life.
Total Raised: Unknown (Y Combinator backed)
Last Round: Summer 2018
Total Raised: Unknown (Y Combinator backed)
Last Round: Summer 2018
Healthcare
Healthcare
Healthcare -> Therapeutics
Healthcare -> Therapeutics
Team size: 4
Hiring: No
Team size: 4
Hiring: No
